A Bioinformatics Approach for the Phenotype Prediction of Nonsynonymous Single Nucleotide Polymorphisms in Human Cytochromes P450
- 9 February 2009
- journal article
- Published by American Society for Pharmacology & Experimental Therapeutics (ASPET)
- Vol. 37 (5), 977-991
- https://doi.org/10.1124/dmd.108.026047
Abstract
Nonsynonymous single nucleotide polymorphisms (nsSNPs) in coding regions that can lead to amino acid changes may cause alteration of protein function and account for susceptivity to disease and altered drug response. Identification of deleterious nsSNPs from tolerant nsSNPs is important for characterizing the genetic basis of human disease, assessing individual susceptibility to disease, understanding the pathogenesis of disease, identifying molecular targets for drug treatment, and conducting individualized pharmacotherapy. Numerous nsSNPs have been found in genes coding for human cytochromes P450 (P450s), but there is poor knowledge on the relationship between the genotype and phenotype of nsSNPs in P450s. We have identified 791 validated nsSNPs in 57 validated human CYP genes from the National Center for Biotechnology Information Database of Single Nucleotide Polymorphism and Swiss-Prot database. Using the polymorphism phenotyping (PolyPhen; http://genetics.bwh.harvard.edu/pph) and sorting intolerant from tolerant (SIFT; http://blocks.fhcrc.org/sift/SIFT.html) algorithms, 39 to 43% of nsSNPs in CYP genes were predicted to have functional impacts on protein function. There was a significant concordance between the predicted results using the SIFT and PolyPhen algorithms. A prediction accuracy analysis found that approximately 70% of nsSNPs were predicted correctly as damaging. Of nsSNPs predicted as deleterious, the prediction scores by the SIFT and PolyPhen algorithms were significantly associated with the numbers of nsSNPs with known phenotype confirmed by benchmarking studies, including site-directed mutagenesis analysis and clinical association studies. These amino acid substitutions are supposed to be the pathogenetic basis for the alteration of P450 enzyme activity and the association with disease susceptivity. This prediction analysis of nsSNPs in human CYP genes would be useful for further genotype-phenotype studies on individual differences in drug clearance and clinical response.Keywords
This publication has 58 references indexed in Scilit:
- Characterization of CYP2A13*2, a Variant Cytochrome P450 Allele Previously Found to Be Associated with Decreased Incidences of Lung Adenocarcinoma in SmokersDrug Metabolism and Disposition, 2008
- Tackling complexityNature, 2002
- Novel Mutations in CYP21 Detected in Individuals with HyperandrogenismJournal of Clinical Endocrinology & Metabolism, 2002
- Characterization of disease-associated single amino acid polymorphisms in terms of sequence and structure properties 1 1Edited by J. ThorntonJournal of Molecular Biology, 2002
- Clinical Significance of the Cytochrome P450 2C19 Genetic PolymorphismClinical Pharmacokinetics, 2002
- Effectiveness of computational methods in haplotype predictionHuman Genetics, 2001
- Pitfalls in Characterizing P450c17 Mutations Associated with Isolated 17,20-Lyase DeficiencyJournal of Clinical Endocrinology & Metabolism, 2001
- CYP2A6*6, a Novel Polymorphism in Cytochrome P450 2A6, Has a Single Amino Acid Substitution (R128Q) That Inactivates Enzymatic ActivityPublished by Elsevier BV ,2001
- Predicting the functional consequences of non-synonymous single nucleotide polymorphisms: structure-based assessment of amino acid variationJournal of Molecular Biology, 2001
- Identification and characterisation of novel polymorphisms in the CYP2A locus: implications for nicotine metabolismFEBS Letters, 1999